| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | D Uebelhart | |
| P921 | main subject | osteoarthritis | Q62736 |
| P304 | page(s) | S19-21 | |
| P577 | publication date | 2008-07-31 | |
| P1433 | published in | Osteoarthritis and Cartilage | Q7107605 |
| P1476 | title | Clinical review of chondroitin sulfate in osteoarthritis | |
| P478 | volume | 16 Suppl 3 |
| Q88801201 | A hyaluronic acid- and chondroitin sulfate-based medical device improves gastritis pain, discomfort, and endoscopic features |
| Q37951364 | Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromolecule |
| Q39906208 | Anticytokine therapy for osteoarthritis: evidence to date |
| Q35131282 | Biphasic role of chondroitin sulfate in cardiac differentiation of embryonic stem cells through inhibition of Wnt/β-catenin signaling |
| Q35092924 | Bone resorption and remodeling in murine collagenase-induced osteoarthritis after administration of glucosamine |
| Q39654702 | C4ST-1/CHST11-controlled chondroitin sulfation interferes with oncogenic HRAS signaling in Costello syndrome |
| Q38838064 | Chondroitin sulphate: a focus on osteoarthritis |
| Q84448818 | Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI |
| Q35147261 | Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids |
| Q34069452 | Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosis |
| Q42404046 | Inhibition by chondroitin sulfate E can specify functional Wnt/β-catenin signaling thresholds in NIH3T3 fibroblasts |
| Q47328575 | KfoA, the UDP-glucose-4-epimerase of Escherichia coli strain O5:K4:H4, shows preference for acetylated substrates. |
| Q26774227 | Marine Non-Glycosaminoglycan Sulfated Glycans as Potential Pharmaceuticals |
| Q49608435 | Pathways to understanding the genomic aetiology of osteoarthritis |
| Q37611121 | Quality of different chondroitin sulfate preparations in relation to their therapeutic activity |
| Q35700763 | Role of gold nanoparticles as drug delivery vehicles for chondroitin sulfate in the treatment of osteoarthritis |
| Q92691743 | Scientific Papers and Patents on Substances with Unproven Effects. Part 2 |
| Q37346515 | The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance |
| Q36840422 | The effects of different molecular weight chondroitin-4-sulfates in chondrocyte pellet culture |
| Q91941601 | The proximal interphalangeal joint: arthritis and deformity |
| Q41118898 | Tools of gene transfer applied to the intracellular delivery of non-nucleic acid polyanionic drugs |
Search more.